{"id":"NCT02318706","sponsor":"Daiichi Sankyo Co., Ltd.","briefTitle":"DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain","officialTitle":"An Asian, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled 14-Week Study of DS-5565 in Patients With Diabetic Peripheral Neuropathic Pain Followed by a 52-Week Open-label Extension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01","primaryCompletion":"2017-06-29","completion":"2017-06-29","firstPosted":"2014-12-17","resultsPosted":"2020-11-02","lastUpdate":"2020-11-02"},"enrollment":854,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Peripheral Neuropathic Pain"],"interventions":[{"type":"DRUG","name":"DS-5565","otherNames":["mirogabalin"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"placebo","type":"PLACEBO_COMPARATOR"},{"label":"DS-5565 15mg","type":"EXPERIMENTAL"},{"label":"DS-5565 20 mg group","type":"EXPERIMENTAL"},{"label":"DS-5565 30 mg group","type":"EXPERIMENTAL"}],"summary":"Investigate the efficacy and safety of DS-5565 in subjects with Diabetic Peripheral Neuropathic Pain (DPNP) in comparison to placebo","primaryOutcome":{"measure":"Change in the Average Daily Pain Score (ADPS) From Baseline to Week 14 Following Administration of DS-5565 in Participants With Diabetic Peripheral Neuropathic Pain","timeFrame":"Baseline to Week 14 (post-dose 1 [15 mg QD] and post-dose 2 [20 mg and 30 mg])","effectByArm":[{"arm":"Placebo","deltaMin":-0.26,"sd":0.79},{"arm":"DS-5565 15mg QD","deltaMin":-0.39,"sd":0.67},{"arm":"DS-5565 20 mg (10 mg BID)","deltaMin":-0.4,"sd":0.85},{"arm":"DS-5565 30 mg (15 mg BID)","deltaMin":-0.6,"sd":1.01}],"pValues":[{"comp":"OG000 vs OG001","p":"0.8773"},{"comp":"OG000 vs OG002","p":"0.3494"},{"comp":"OG000 vs OG003","p":"0.0027"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["34059327"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":330},"commonTop":["Nasopharyngitis","Somnolence","Dizziness","Diabetic retinopathy","Oedema peripheral"]}}